Australia markets close in 4 hours 22 minutes

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
1.9000-0.0500 (-2.56%)
At close: 04:00PM EDT
1.9195 +0.02 (+1.03%)
After hours: 07:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 102.16M
Enterprise value 850.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.10
Price/book (mrq)0.16
Enterprise value/revenue 0.83
Enterprise value/EBITDA -1.64

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-81.48%
S&P500 52-week change 321.61%
52-week high 310.8800
52-week low 31.4200
50-day moving average 32.3702
200-day moving average 33.3150

Share statistics

Avg vol (3-month) 33.02M
Avg vol (10-day) 3943.32k
Shares outstanding 552.39M
Implied shares outstanding 652.39M
Float 851.5M
% held by insiders 11.88%
% held by institutions 179.22%
Shares short (28 Mar 2024) 45.7M
Short ratio (28 Mar 2024) 42.64
Short % of float (28 Mar 2024) 418.02%
Short % of shares outstanding (28 Mar 2024) 410.92%
Shares short (prior month 29 Feb 2024) 46.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -72.48%
Operating margin (ttm)-18.33%

Management effectiveness

Return on assets (ttm)-4.80%
Return on equity (ttm)-74.67%

Income statement

Revenue (ttm)1.05B
Revenue per share (ttm)20.49
Quarterly revenue growth (yoy)-16.20%
Gross profit (ttm)N/A
EBITDA -70.7M
Net income avi to common (ttm)-760.5M
Diluted EPS (ttm)-14.8500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)111.7M
Total cash per share (mrq)2.14
Total debt (mrq)877.5M
Total debt/equity (mrq)135.15%
Current ratio (mrq)1.04
Book value per share (mrq)12.44

Cash flow statement

Operating cash flow (ttm)-206.3M
Levered free cash flow (ttm)-103.41M